Tilray Brands (TLRY) Net Margin (2017 - 2026)
Tilray Brands' (TLRY) quarterly Net Margin came in at 10.52% in Q2 2026, up 39263.0% YoY from N/an in Q2 2025, and up 13.81% on a QoQ basis from 12.21% in Q1 2026.
Tilray Brands (TLRY) Net Margin (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Net Margin data on file, last reported at 10.52% in Q2 2026.
- Quarterly Net Margin rose 39263.0% year-over-year to 10.52% in Q2 2026, while the trailing twelve-month figure through May 2026 was 10.58% (up 21085.0% YoY) and the FY2026 annual result came in at 10.58%, up 21085.0% from the prior year.
- Net Margin advanced to 10.52% in Q2 2026, from 12.21% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 96.39% in Q2 2023 to a low of 821.32% in Q1 2023.
- A 5-year average of 115.11% and a median of 27.7% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin plunged 85587 bps — and 2024, when it soared 76558 bps.
- Tracing TLRY's Net Margin over 5 years: stood at 59.01% in 2022, then soared by 60 bps to 23.83% in 2023, then plunged by 70 bps to 40.42% in 2024, then jumped by 51 bps to 20.0% in 2025, then jumped by 47 bps to 10.52% in 2026.
- The last three Net Margin figures came in at 10.52% (Q2 2026), 12.21% (Q1 2026), and 20.0% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -10.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -10.52% |
| Feb 28, 2026 | -12.21% |
| Nov 30, 2025 | -20.00% |
| Aug 31, 2025 | 0.72% |
| May 31, 2025 | -403.15% |
| Feb 28, 2025 | -427.14% |
| Nov 30, 2024 | -40.42% |
| Aug 31, 2024 | -17.32% |
| May 31, 2024 | 4.06% |
| Feb 29, 2024 | -55.74% |
| Nov 30, 2023 | -23.83% |
| Aug 31, 2023 | -31.57% |
| May 31, 2023 | 96.39% |
| Feb 28, 2023 | -821.32% |
| Nov 30, 2022 | -59.01% |
| Aug 31, 2022 | -42.94% |
| May 31, 2022 | -242.49% |
| Feb 28, 2022 | 34.55% |
| Nov 30, 2021 | 3.74% |
| Aug 31, 2021 | -20.59% |